Navigation Links
Governor Rendell Appoints Members of Chronic Care Commission as Part of Prescription for PA
Date:9/17/2007

HARRISBURG, Pa., Sept. 17 /PRNewswire-USNewswire/ -- Governor Edward G. Rendell has appointed 37 individuals to a commission that will work to improve how Pennsylvanians with chronic disease receive health care in the future. The initiative is part of the Governor's Prescription for Pennsylvania health care reform plan.

"About 78 percent of all health care costs in Pennsylvania are attributable to 20 percent of all patients -- those with chronic diseases," Governor Rendell said. "The members of the Chronic Care Management Commission will help to develop processes to more effectively manage chronic disease. We cannot reduce the occurrence and cost of chronic diseases without aggressively addressing prevention, detection and treatment in a comprehensive, proactive way."

The Governor said that in 2005, Pennsylvania hospitals reported more than $1.7 billion in hospital charges for potentially avoidable hospitalizations because patients with chronic conditions did not receive necessary care in the community.

The 37 commission members represent a broad cross section of health care related fields and represent all geographic areas of the state. In addition, the secretaries of Health, Public Welfare and Insurance and the director of the Governor's Office of Health Care Reform serve as ex-officio members of the commission.

The commission is holding its first meeting today in Harrisburg and will hold additional meetings in the coming months. The Governor's Executive Order creating the commission calls for it to develop a strategic plan including a blueprint for evaluation within 90 days of its first meeting.

For more information on Governor Rendell's Prescription for Pennsylvania reform plan, visit http://www.rxforpa.com.

The Rendell administration is committed to creating a first-rate public education system, protecting our most vulnerable citizens and continuing economic investment
'/>"/>

SOURCE Pennsylvania Office of the Governor
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Vermont Governor steps in with a new health insurance plan.
2. Arkansas Governor Explains New Health Plan Insurance On Radio Show
3. Massachusetts Governor To Sign Health Coverage Bill
4. Aids Seems More Prevalent Among Goan’s – Governor Visiond
5. Tamil Nadu Emerging As Model State In Public Health Care: Governor
6. The National Governors Association Releases Guidelines For Outbreak Of Bird Flu
7. New York Governor to Introduce Bill to Strengthen Abortion Rights
8. Maverick Gay Ex-governor Turns a New Leaf - Accepted at the Episcopalian Seminary
9. Maverick Gay Ex-governor Turns a New Leaf - Accepted at the Episcopalian Seminary
10. Gov. Ed Rendell Plan Would Widen Health Insurance
11. IMA wants members not to do sex determination tests during pregnancy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...linical trial results could lead to availability o...eatment for deep lines and wrinkles by 2009. , ... 24, 2008 -- Gel-Del Technologies , a St. Paul, M... that it has concluded clinical trials of CosmetaL...als say holds potential to be a more effective alt...
(Date:7/24/2008)...ll/ --, Key Highlights, Misys plc (LSE: MSY) del...sing targets for the next phase of the turnaround....%, bringing Group operating profit(2) to GBP81m,3...trategy and entering,into the next phase of the tu...o view the Multimedia News Release, please click:,...
(Date:7/23/2008)...wire/ -- MediVoice(R), LLC, the,world,s first mobi...escribing, has formed a strategic partnership with... web-based, patient-centered health record,managem...e and market its,mobile voice-activation solution ...., "MediVoice is pleased to develop a strategic p...
(Date:7/23/2008)..., July 23 /PRNewswire-FirstCall/ - Cardiome Pharma...t it has entered into an,agreement with CR Intrins...,CR Intrinsic Investors, LLC, an affiliate of S.A....ertible preferred shares for gross proceeds of,US$... for general corporate,purposes, costs associated ...
Breaking Medicine News(10 mins):Health News:Clinical Trial Concluded For New Wrinkle Treatment 2Health News:Clinical Trial Concluded For New Wrinkle Treatment 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 2Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 4Health News:MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management System 2Health News:MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management System 3Health News:Cardiome Announces Preferred Share Financing 2Health News:Cardiome Announces Preferred Share Financing 3
.... Ragnfrid H. Nordbo, of the Norwegian Institute o...d set of people// suffering anorexia nervosa, a fo...his mental disease attribute a great deal of impor...a deep seated need or emotion. In his estimate, t...
...n, 81, the famous Pulitzer Prize-winning novelist,...usetts.// According to his daughter, Alexandra, he... He belonged to Virginia. He was obsessive about r...im write novels like "Lie Down In Darkness" and "T...
...a government data, the number of deaths due to alc...The Office for National Statistics (ONS) revealed ... in the year 1991 and it has risen to 8,386 by las...s, the lower price and easy accessibility are resp...
...hich has been one of the major causes of death in ...and in the next two decades// according to the Chi...Dr Harry Burns, "In the 1960s, one in 100 men died...ing all the time and, thanks to the smoking ban, I...
Other Medicine News:Health News:Deaths due to heavy drinking has doubled in 15 years 2Health News:Eradication of Lung Cancer in 20 years 2Health News:Eradication of Lung Cancer in 20 years 3
(Date:7/22/2008)...y Demonstrates Feasibility and Efficacy of Treatin...iver Cancer, SAN FRANCISCO, and YONGIN-SI, South ... Francisco, CA and Ottawa, Ontario), and its South... that novel findings from,a Phase I clinical trial...rated that the product was well-tolerated and resu...
(Date:7/22/2008)...TH SAN FRANCISCO, Calif., July 22 /- ...t has completed patient enrollment,in its Phase 1/...ity and,ammonia scavenging effects of HPN-100 (for...ylbutyrate) in patients with urea cycle disorders,...lts in the fourth quarter,of this year., (Logo: ...
(Date:7/22/2008)...HIA ANTIPOLIS, France, July 22 /PRNewswire-FirstCa...unced it has successfully completed the,enrollment...ed hypertension,in two clinical pharmacology studi...nnounced timelines. These trials are designed to a...n comparison to ibuprofen and,naproxen, using the ...
(Date:7/21/2008)... YORK, July 21 /- Ari Kiev, M.D., pre... speaker at the upcoming conference Wall,Street Un...ement,s Guide to,Wall Street. The conference will ...errace, 267 Fifth Avenue in New York. The event is...d mid-cap life science companies to gain,better in...
Breaking Medicine Technology:Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3Coherent Inc to Webcast First Fiscal Quarter 2008 Results 9937 1Dave Perbix Named Vice President Occupational Health Sales and Marketing for Kaiser Permanente 9933 1Dave Perbix Named Vice President Occupational Health Sales and Marketing for Kaiser Permanente 9933 2Vapotherm 28R 29 Announces Validation of U S Patent 2694 1Vapotherm 28R 29 Announces Validation of U S Patent 2694 2Clinimetrics Celebrates 20th Anniversary in Contract Research Business 2690 1
...FirstCall/ -- Vical,Incorporated today announced t...d positive results following interim analysis of d... 3 trial of an,angiogenesis product candidate usin...ndings that the primary efficacy,endpoint in the t...ce and that there were no major safety concerns re...
...AMADEO, one of the,first studies to compare the p...ockers in hypertensive patients with,diabetic nep...f Hypertension, Milan. The results from this study...ignificantly greater extent,than losartan.(1) ...ss, Foothills Hospital,in Calgary, Canada said "T...
Other Medicine Technology:Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 2Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 3Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 4Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 5New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 2New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 3New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 4New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 5
Anti Gliadin IgA Enzyme Immunosay for quantitative determination of Gliadin-IgG antibodies in serum.
...igned as a high throughput primary or backup instr...r offers performance and reliability equal to or g...advanced technology of the AUTION JET AJ-4270 and ...ate results, limiting interference from elevated p...
Assay uses highly specific rabbit anti-estriol antibody reparation - negligible cross-reactivity with other estrogen metabolites. Excellent assay precision and reproducibility. Superior sensitivity
...rone Sulfate (E1S) is the most abundant circulatin... men [1,2]. Estrone Sulfate is a major metabolite ...fe in blood [2,3]. In premenopausal women, estrone...e and estradiol, rising gradually during the folli...
Medicine Products: